CDIOW | Cardio Diagnostics Holdings, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.0250 - 0.0315
52 Week Range	0.0250 - 0.0315
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	2,644
Average Volume	N/A
Shares Outstanding	205,404,999
Market Cap	6,470,257
Sector	Healthcare
Industry	Biotechnology
IPO Date	N/A

Valuation
Profitability
Growth
Health
P/E Ratio	N/A
Forward P/E Ratio	N/A
EPS	N/A
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	7
Country	USA
Website	CDIOW

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.

CDIOW's peers: ICUCW

*Chart delayed

Analyzing fundamentals for CDIOW we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see CDIOW Fundamentals page.

Watching at CDIOW technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on CDIOW Technicals page.